Uzm. Dr. Emine Kanatsız
Is this your profile? Claim it and verify your details.
Claim profileTrust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyGastroenterologysaglik.gov.trFrom source
- InstitutionÜmraniye Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Publications6 publicationsOpenAlex, Europe PMC, ORCIDFrom source
- ORCID0000-0003-2971-6443ORCIDFrom source
- Last synchronised5 November 2026 08:56https://umraniyeah.saglik.gov.tr/TR-1514391/doktorlarimiz.html#emine-kanatsizsaglik.gov.tr
Scientific work
Publications
-
Association of Metastatic Lymph Node Count and Primary Tumor Size with Disease-Free Survival in Stage II–III Gastric Cancer: A Retrospective Cohort Study
Medicina, 2026
DOI 10.3390/medicina62081528 PMID 42654425 Open-access full textSource: OpenAlex
-
Precision in practice: The diagnostic yield of endoscopic ultrasound guided fine needle aspiration/fine needle biopsy cytology in pancreatic mass lesions
CytoJournal, 2025
DOI 10.25259/cytojournal_161_2025 PMID 41664700 Open-access full textSource: Europe PMC
-
Diagnostic Prevalence of Celiac Disease by Routine Duodenum Biopsy in Adult Patients with Iron Deficiency
Bagcilar Medical Bulletin, 2023
DOI 10.4274/bmb.galenos.2023.2023-05-051 1 citation (OpenAlex) Open-access full textSource: ORCID
-
Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment
World Journal of Gastroenterology, 2022
DOI 10.3748/wjg.v28.i6.665 PMID 35317422 10 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Influence of sustained virological responseon apri in chronic hepatitis c: Is APRI a marker of only the stage of fibrosis?,Kronik Hepatit C'de Sürekli Virolojik Yanıtın APRI Üzerindeki Etkisi: APRI Sadece Fibrozis Evresinin Bir Belirteci mi?
Viral Hepatitis Journal, 2021
DOI 10.4274/vhd.galenos.2020.2020.0012 1 citation (OpenAlex) Open-access full textSource: ORCID
-
Efficacy and safety of Paritaprevir/Ritonavir + Ombitasvir ± Dasabuvir ± Ribavirin in chronic hepatitis C patients with chronic renal failure
The Turkish Journal of Gastroenterology, 2019
DOI 10.5152/tjg.2019.18 Open-access full textSource: OpenAlex